Shalabh Gupta
Founder, President & CEO
biotechnology
Globavir Biosciences, Inc.
United States of America
Biography
Shalabh Gupta, MD, MPA is the founder and CEO of Globavir, Inc. In early 2011, Dr. Gupta founded BioCycive Inc., a biotechnology company focused on oncology. BioCycive’s lead program, BC 001, was partnered with Sorrento Therapeutics and then with Nantworks LLC in 2015. BioCycive later became Globavir’s wholly owned subsidiary.
Research Interest
infectious diseases and oncology
